AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading ABBV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-1.88%33.941.4%$874.81m
JNJJohnson & Johnson
-1.46%115.670.8%$778.66m
ABBVAbbVie, Inc.
-2.37%59.861.7%$554.64m
MRKMerck & Co., Inc.
-3.07%55.911.0%$514.37m
BMYBristol-Myers Squibb Company
-2.80%70.611.1%$442.28m
LLYEli Lilly and Company
0.53%74.340.8%$307.00m
GSKGlaxoSmithKline plc Sponsored ADR
-4.09%40.820.2%$157.28m
NVSNovartis AG Sponsored ADR
-4.41%77.110.2%$143.40m
AZNAstraZeneca PLC Sponsored ADR
-4.85%27.870.9%$137.13m
NVONovo Nordisk A/S Sponsored ADR Class B
-4.38%51.060.1%$85.28m
SNYSanofi Sponsored ADR
-6.63%38.460.2%$72.28m
LCILannett Company, Inc.
-3.58%24.2527.9%$17.00m
SCMPSucampo Pharmaceuticals, Inc. Class A
-2.19%10.714.1%$5.91m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.34%13.440.2%$0.07m
EPIXESSA Pharma Inc
-1.02%2.900.0%$0.01m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on April 10, 2012 and is headquartered in North Chicago, IL.